What is the price target for HTGM stock?
7 analysts have analysed HTGM and the average price target is 6.12 USD. This implies a price increase of 1175% is expected in the next year compared to the current price of 0.48.
HTG MOLECULAR DIAGNOSTICS (HTGM) Forecast, Price Target & Analyst Ratings
NASDAQ:HTGM • US40434H3021
Current stock price
0.48 USD
-0.12 (-20%)
At close:
0.4815 USD
+0 (+0.31%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HTG MOLECULAR DIAGNOSTICS (HTGM).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Aug 9, 2023
- Period
- Q2 / 2023
- EPS Estimate
- -$1.88
- Revenue Estimate
- 1.632M
Price Target Details & History
Consensus Price Target and Range
Mean target
$6.12
Upside
+ 1,175.00%
From current price of $0.48 to mean target of $6.12, Based on 7 analyst forecasts
Low
$6.06
Median
$6.12
High
$6.30
Price Target Revisions
1 Month
0.00%
3 Months
-40.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for HTGM. The average price target is 6.12 USD. This implies a price increase of 1175% is expected in the next year compared to the current price of 0.48.
The average price target has been revised downward by 40% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
HTGM was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about HTGM.
In the previous month the buy percentage consensus was at a similar level.
HTGM was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-04-19 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-03 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-16 | HC Wainwright & Co. | Maintains | Buy |
| 2022-01-07 | Craig-Hallum | Upgrade | Hold -> Buy |
| 2021-05-14 | SVB Leerink | Maintains | Outperform |
| 2021-05-14 | HC Wainwright & Co. | Maintains | Buy |
| 2021-03-26 | HC Wainwright & Co. | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Aug 9, 2023
- Period
- Q2 / 2023
- EPS Estimate
- -$1.88
- Revenue Estimate
- 1.632M
- Revenue Q2Q
- 9.41%
- EPS Q2Q
- 71.04%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-28.89%
EPS (1 Month)
0.00%
EPS (3 Months)
-162.86%
Next Earnings Summary
HTGM is expected to report earnings on 8/9/2023. The consensus EPS estimate for the next earnings is -1.88 USD and the consensus revenue estimate is 1.63M USD.
The next earnings revenue estimate has been revised downward by 28.89% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2023 - 2024
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.55M -55.47% | 8.907M 4.17% | 6.366M -28.52% | 6.528M 2.54% | 15.3M 134.38% | |
| EBITDA YoY % growth | -18.24M -3.05% | -17.103M 6.24% | -20.242M -18.36% | N/A | N/A | |
| EBIT YoY % growth | -19.59M -3.32% | -17.824M 9.02% | -20.83M -16.86% | -15.616M 25.03% | -22.44M -43.70% | |
| Operating Margin | -229.12% | -200.11% | -327.19% | -239.22% | -146.67% | |
| EPS YoY % growth | -52.56 43.85% | -32.88 37.44% | -25.59 22.16% | -4.72 81.55% | -1.08 77.11% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|
| EPS Q2Q % growth | -1.88 71.04% | -1.03 79.06% | -0.67 84.95% |
| Revenue Q2Q % growth | 1.632M 9.41% | 1.632M 30.47% | 1.632M -33.10% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.968M 30.11% | -3.815M 12.26% | -3.662M 19.53% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
HTG MOLECULAR DIAGNOSTICS / HTGM Forecast FAQ
What is the next earnings date for HTGM stock?
HTG MOLECULAR DIAGNOSTICS (HTGM) will report earnings on 2023-08-09, after the market close.
Can you provide the consensus estimates for HTG MOLECULAR DIAGNOSTICS next earnings?
The consensus EPS estimate for the next earnings of HTG MOLECULAR DIAGNOSTICS (HTGM) is -1.88 USD and the consensus revenue estimate is 1.63M USD.
What is the consensus rating for HTGM stock?
The consensus rating for HTG MOLECULAR DIAGNOSTICS (HTGM) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.